Investing in Zevra Therapeutics (NASDAQ:ZVRA) Five Years Ago Would Have Delivered You a 83% Gain

Yahoo FinanceMar 4 06:29 ET

Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsFeb 28 12:33 ET · Ratings

Zevra Therapeutics: Strategic Growth and Financial Strength Drive Buy Rating

TipRanksFeb 28 11:45 ET · Ratings

Zevra Therapeutics Launches New Disease State Awareness Campaign

TipRanksFeb 28 07:36 ET

Zevra Launches New Disease State Awareness Campaign, 'Learn NPC, Read Between the Signs,' to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C

GlobeNewswireFeb 28 07:30 ET

Express News | Zevra Launches New Disease State Awareness Campaign, ‘Learn Npc, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C

ReutersFeb 28 07:30 ET